沈洪兵 + 关注学者
  • 认领成果数 900
  • wos被引 8,286
  • wos篇均被引 19.31

按条件检索“3”条记录

已选条件:
导出
  • 排序
  • 显示
2. PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1 PubMed SCIE SCOPUS 认领

作者:Chen, ZQ;<a href='http://ir.njmu.edu.cn/widgets/sdjgk/?h=scholar&job=org&a_id=239891' class='f_htr_a' target='_blank'> Gao, W</a>; Pu, LY; Zhang, L; Han, GY; Zuo, XL; Zhang, Y; Li, XC; Shen, HB; Wu, JD; Wang, XH

作者机构:[Chen, Zhiqiang; Pu, Liyong; Zhang, Long; Han, Guoyong; Zuo, Xueliang; Zhang, Yao; Li, Xiangcheng; Wu, Jindao; Wang, Xuehao] Nanjing Med Univ, Dept He 更多

来源:HEPATOLOGY,2018,Vol.68,Issue.3

Scopus被引频次:1

ESI学科:CLINICAL MEDICINE

最新一期影响因子:13.246

资源类型:外文期刊论文

3. 5-Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT-Dependent and Independent Manners PubMed SCOPUS 认领

作者:Zuo X.; Chen Z.; Cai J.; Gao W.; Zhang Y.; Han G.; Pu L.; Wu Z.; You W.; Qin J.; Dai X.; Shen H.; Wu J.; Wang X.

作者机构:[Zuo, X] Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University;[ Key Laboratory of Liver Transplantation] Chinese Academy 更多

来源:Hepatology,2019,Vol.69,Issue.5

资源类型:外文期刊论文

TOP